These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 18160611)

  • 1. Further insight into the heparin-releasable and glycosylphosphatidylinositol-lipid--anchored forms of tissue factor pathway inhibitor.
    Ellery PE; Hardy K; Oostryck R; Adams MJ
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):267-78. PubMed ID: 18160611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosyl phosphatidylinositol anchorage of tissue factor pathway inhibitor.
    Zhang J; Piro O; Lu L; Broze GJ
    Circulation; 2003 Aug; 108(5):623-7. PubMed ID: 12835228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fucoidan, as heparin, induces tissue factor pathway inhibitor release from cultured human endothelial cells.
    Giraux JL; Tapon-Bretaudière J; Matou S; Fischer AM
    Thromb Haemost; 1998 Oct; 80(4):692-5. PubMed ID: 9798992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the association of tissue factor pathway inhibitor with human placenta.
    Mast AE; Acharya N; Malecha MJ; Hall CL; Dietzen DJ
    Arterioscler Thromb Vasc Biol; 2002 Dec; 22(12):2099-104. PubMed ID: 12482841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crucial roles of GATA-2 and SP1 in adrenomedullin-affected expression of tissue factor pathway inhibitor in human umbilical vein endothelial cells exposed to lipopolysaccharide.
    Liu W; Zhu ZQ; Wang W; Zu SY; Zhu GJ
    Thromb Haemost; 2007 May; 97(5):839-46. PubMed ID: 17479196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravascular release and urinary excretion of tissue factor pathway inhibitor during heparin treatment.
    Brodin E; Svensson B; Paulssen RH; Nordoy A; Hansen JB
    J Lab Clin Med; 2004 Nov; 144(5):246-53; discussion 226-7. PubMed ID: 15570242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro.
    Hansen JB; Svensson B; Olsen R; Ezban M; Osterud B; Paulssen RH
    Thromb Haemost; 2000 Jun; 83(6):937-43. PubMed ID: 10896252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue factor pathway inhibitor production by human mesangial cells in culture.
    Yamabe H; Osawa H; Inuma H; Kaizuka M; Tamura N; Tsunoda S; Fujita Y; Shirato K; Onodera K
    Thromb Haemost; 1996 Aug; 76(2):215-9. PubMed ID: 8865534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of unfractionated heparin and a low molecular weight heparin (enoxaparin) on coagulant activity of cultured human endothelial cells.
    Martinez-Sales V; Vila V; Réganon E; Oms JG; Aznar J
    Haematologica; 2003 Jun; 88(6):694-9. PubMed ID: 12801846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of full length and two-domain tissue factor pathway inhibitor in combination with heparin in rabbits.
    Bregengaard C; Nordfang O; Ostergaard P; Petersen JG; Meyn G; Diness V; Svendsen O; Hedner U
    Thromb Haemost; 1993 Sep; 70(3):454-7. PubMed ID: 8259548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
    Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
    Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that the C-terminus of tissue factor pathway inhibitor (TFPI) is essential for its in vitro and in vivo interaction with lipoproteins.
    Valentin S; Nordfang O; Bregengård C; Wildgoose P
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):713-20. PubMed ID: 8292720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of native VLDL on tissue factor pathway inhibitor in endothelial cells and interactions between TFPI and lipoprotein lipase.
    Brodin E; Iversen N; Hansen JB
    J Lab Clin Med; 2006 Apr; 147(4):167-73. PubMed ID: 16581344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role for the Kunitz-3 domain of tissue factor pathway inhibitor-alpha in cell surface binding.
    Piro O; Broze GJ
    Circulation; 2004 Dec; 110(23):3567-72. PubMed ID: 15557366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of C-reactive protein on the release of tissue factor pathway inhibitor from human endothelial cells: reversal by low molecular weight heparin.
    Mousa SA
    Int Angiol; 2006 Mar; 25(1):10-3. PubMed ID: 16520718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative quantification of glycosaminoglycan-induced upregulation of TFPI-mRNA expression in vitro.
    Thyzel E; Kohli S; Siegling S; Prante C; Kleesiek K; Götting C
    Thromb Res; 2007; 119(6):785-91. PubMed ID: 16919311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of glycosylphosphatidylinositol-anchored carboxypeptidase M by phosphatidylinositol-specific phospholipase C upregulates enzyme synthesis.
    Li XY; Skidgel RA
    Biochem Biophys Res Commun; 1999 Apr; 258(1):204-10. PubMed ID: 10222261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRP regulates the expression and activity of tissue factor as well as tissue factor pathway inhibitor via NF-kappaB and ERK 1/2 MAPK pathway.
    Chen Y; Wang J; Yao Y; Yuan W; Kong M; Lin Y; Geng D; Nie R
    FEBS Lett; 2009 Sep; 583(17):2811-8. PubMed ID: 19631649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue factor pathway inhibitor: proposed heparin recognition region.
    Harenberg J; Malsch R; Heene DL
    Blood Coagul Fibrinolysis; 1995 Jun; 6 Suppl 1():S50-6. PubMed ID: 7647222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of heparin-releasable TFPI are increased in first-ever lacunar stroke patients.
    Knottnerus IL; Winckers K; Ten Cate H; Hackeng TM; Lodder J; Rouhl RP; Staals J; Govers-Riemslag JW; Bekers O; van Oostenbrugge RJ
    Neurology; 2012 Feb; 78(7):493-8. PubMed ID: 22302552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.